CN1095377C - Medicine for treating skin ringworm and dermatitis and preparation process - Google Patents
Medicine for treating skin ringworm and dermatitis and preparation process Download PDFInfo
- Publication number
- CN1095377C CN1095377C CN99116454A CN99116454A CN1095377C CN 1095377 C CN1095377 C CN 1095377C CN 99116454 A CN99116454 A CN 99116454A CN 99116454 A CN99116454 A CN 99116454A CN 1095377 C CN1095377 C CN 1095377C
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- skin
- treating skin
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 67
- 208000002474 Tinea Diseases 0.000 title claims abstract description 20
- 241000893966 Trichophyton verrucosum Species 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 229940079593 drug Drugs 0.000 title description 26
- 201000004624 Dermatitis Diseases 0.000 title description 8
- 229940098465 tincture Drugs 0.000 claims abstract description 10
- 244000080767 Areca catechu Species 0.000 claims abstract description 8
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 8
- 206010061218 Inflammation Diseases 0.000 claims abstract description 8
- 241000110847 Kochia Species 0.000 claims abstract description 8
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 8
- 239000008280 blood Substances 0.000 claims abstract description 8
- 210000004369 blood Anatomy 0.000 claims abstract description 8
- 230000004054 inflammatory process Effects 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 229940037003 alum Drugs 0.000 claims abstract description 7
- 235000021419 vinegar Nutrition 0.000 claims abstract description 5
- 239000000052 vinegar Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 244000144927 Aloe barbadensis Species 0.000 claims description 7
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 7
- 244000163122 Curcuma domestica Species 0.000 claims description 7
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 7
- 235000003373 curcuma longa Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 235000013976 turmeric Nutrition 0.000 claims description 7
- 241000037740 Coptis chinensis Species 0.000 claims description 5
- 206010012504 Dermatophytosis Diseases 0.000 claims description 3
- 241001460074 Microsporum distortum Species 0.000 claims description 3
- DHZBEENLJMYSHQ-XCVPVQRUSA-N cantharidin Chemical compound C([C@@H]1O2)C[C@@H]2[C@]2(C)[C@@]1(C)C(=O)OC2=O DHZBEENLJMYSHQ-XCVPVQRUSA-N 0.000 claims 2
- 229940095758 cantharidin Drugs 0.000 claims 2
- 229930008397 cantharidin Natural products 0.000 claims 2
- DHZBEENLJMYSHQ-UHFFFAOYSA-N cantharidine Natural products O1C2CCC1C1(C)C2(C)C(=O)OC1=O DHZBEENLJMYSHQ-UHFFFAOYSA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 21
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 18
- 241001480043 Arthrodermataceae Species 0.000 abstract description 6
- 230000037304 dermatophytes Effects 0.000 abstract description 6
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 229940088710 antibiotic agent Drugs 0.000 abstract description 4
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract description 3
- 231100000053 low toxicity Toxicity 0.000 abstract description 3
- 239000002552 dosage form Substances 0.000 abstract description 2
- 241001116389 Aloe Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 241000124079 Mylabris Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 238000010790 dilution Methods 0.000 description 10
- 239000012895 dilution Substances 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 8
- 229960004022 clotrimazole Drugs 0.000 description 8
- 210000005069 ears Anatomy 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 206010040844 Skin exfoliation Diseases 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 201000004647 tinea pedis Diseases 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 206010048038 Wound infection Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000035618 desquamation Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000218202 Coptis Species 0.000 description 2
- 241001480035 Epidermophyton Species 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000032536 Pseudomonas Infections Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 241001459572 Trichophyton interdigitale Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241001467018 Typhis Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000629 anti-dermatophyte Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种治疗皮肤癣症、炎症的药物及其制备方法,它是由下述重量配比的原料制成的药剂:血竭25-35克、郁金80-120克、黄连100-200克、白矾80-120克、槟榔100-200克、芦荟80-120克、大风子40-60克、地肤子100-150克、斑蝥40-60克,本发明采用中药黄连为主药的制剂,剂型为酊剂或醋剂,其中不含抗生素,毒性低、副作用小、疗效高、有效期长,不仅能对皮肤癣菌有明显的抗菌作用,还有较好的杀菌作用。A medicine for treating skin ringworm and inflammation and a preparation method thereof, which is a medicament made of the following raw materials in proportion by weight: 25-35 grams of dried blood, 80-120 grams of curcuma, 100-200 grams of rhizoma coptis, 80-120 grams of alum, 100-200 grams of betel nut, 80-120 grams of aloe, 40-60 grams of Fructus Dafeng, 100-150 grams of Kochia scoparia, 40-60 grams of Mylabris, the present invention adopts the preparation of Chinese medicine Coptidis Rhizoma as the main agent, The dosage form is tincture or vinegar, which does not contain antibiotics, has low toxicity, small side effects, high curative effect and long validity period. It not only has obvious antibacterial effect on dermatophyte, but also has better bactericidal effect.
Description
本发明涉及一种治疗皮肤尤其是各种皮肤炎症、癣症的药物,本发明还涉及该药物的制备方法。The invention relates to a medicine for treating skin, especially various skin inflammations and ringworm, and also relates to a preparation method of the medicine.
皮肤癣症在皮肤病中是常见病、多发病,不仅疼痒剧烈,使人难以忍受,有时继发感染,导致全身症状。目前治疗的药物虽然很多,如脚癣一次净,往往需要长时间多次用药,且多有刺激性,腐蚀性大,出现皮肤脱落、烂脚等现象,有的只对手足癣有效,对杀灭细菌无效。Skin ringworm is a common and frequently-occurring disease in skin diseases. It not only has severe pain and itching, which makes people unbearable, but also secondary infection sometimes leads to systemic symptoms. Though the medicine of present treatment is a lot, clean once as athlete's foot, often need long-term repeated medication, and many are irritating, corrosivity is big, and phenomenons such as skin comes off, rotten foot occur, and what have is only effective to exterminate tinea pedis. Bacteria are ineffective.
本发明的目的是提供一种疗效高、刺激性小、收效作用好、使用方便的一种治疗皮肤癣症、炎症的药物及其制备方法。The purpose of the present invention is to provide a medicine for treating skin ringworm and inflammation with high curative effect, little irritation, good effect and convenient use and a preparation method thereof.
本发明的另一目的是提供该药物的制备方法。Another object of the present invention is to provide a preparation method of the medicine.
本发明的目的是这样实现的:一种治疗皮肤癣症、炎症的药物及其制备方法,其特征在于:它是由下述重量配比的原料制成的药剂:The object of the present invention is achieved like this: a kind of medicine for the treatment of dermatophytosis, inflammation and preparation method thereof, is characterized in that: it is the medicament that is made by the raw material of following weight ratio:
血 竭 25-35 克 郁 金 80-120 克Dried blood 25-35 grams Turmeric 80-120 grams
黄 连 100-200克 白 矾 80-120 克Coptis 100-200 grams Alum 80-120 grams
槟 榔 100-200克 芦 荟 80-120 克Betel nut 100-200 grams Aloe vera 80-120 grams
大风子 40-60 克 地肤子 100-150克Dafengzi 40-60 grams Kochia 100-150 grams
斑 蝥 40-60 克Spotted beetle 40-60 grams
其最佳重量配比:Its optimal weight ratio:
血 竭 30 克 郁 金 100克 黄 连 150克Dried Blood 30g Turmeric 100g Coptidis Rhizome 150g
白 矾 100克 槟 榔 150克 芦 荟 100克Alum 100g Betel nut 150g Aloe vera 100g
大风子 50 克 地肤子 150克 斑 蝥 50 克50 grams of Dafengzi 150 grams of Kochia chinensis 50 grams
上述药剂为酊剂或醋剂。其酊剂采用10000毫升,浓度为70%的酒精浸泡上述药剂,常温常压7-10天,过滤即可。醋剂的制备方法采用常规方法制备。The above-mentioned medicament is tincture or vinegar. Its tincture adopts 10000 milliliters, and concentration is that 70% alcohol soaks above-mentioned medicine, normal temperature and normal pressure 7-10 days, gets final product in filtration. The preparation method of vinegar adopts conventional method to prepare.
本发明采用中药黄连为主药的制剂,剂型为酊剂或醋剂,其中不含抗生素,毒性低、副作用小、疗效高、有效期长,不仅能对皮肤癣菌有明显的抗菌作用,还有较好的杀菌作用。The present invention adopts the preparation of Coptis chinensis as the main medicine, and the dosage form is tincture or vinegar, which does not contain antibiotics, has low toxicity, small side effects, high curative effect and long validity period. It not only has obvious antibacterial effect on dermatophytes, but also has relatively Good bactericidal effect.
下面结合实施详细描述本发明:Describe the present invention in detail below in conjunction with implementation:
实施例一:按下述配比称取原料:Embodiment one: take raw material by following proportioning:
血 竭 25克 郁 金 80 克 黄 连 100克Dried Blood 25g Turmeric 80g Coptidis Rhizome 100g
白 矾 80克 槟 榔 100克 芦 荟 80 克Alum 80g Betel nut 100g Aloe vera 80g
大风子 40克 地肤子 100克 斑 蝥 40 克40 grams of Dafengzi 100 grams of Kochia chinensis 40 grams
实施例二:按下述配比称取原料Embodiment two: take raw material by following proportioning
血 竭 35 克 郁 金 120克 黄 连 200克Dried Blood 35g Turmeric 120g Coptis Rhizoma 200g
白 矾 120克 槟 榔 200克 芦 荟 120克Alum 120g Betel nut 200g Aloe vera 120g
大风子 60 克 地肤子 150克 斑 蝥 60 克60 grams of Dafengzi 150 grams of Kochia chinensis 60 grams
实施例三:按下述最佳配比称取原料Embodiment three: take by weighing raw material according to following optimal proportioning
血 竭 30 克 郁 金 100克 黄 连 150克Dried Blood 30g Turmeric 100g Coptidis Rhizome 150g
白 矾 100克 槟 榔 150克 芦 荟 100克Alum 100g Betel nut 150g Aloe vera 100g
大风子 50 克 地肤子 150克 斑 蝥 50 克50 grams of Dafengzi 150 grams of Kochia chinensis 50 grams
上述原料药制备均采用中华人民共和国药典(95版)。The preparation of the above-mentioned raw materials all adopts the Pharmacopoeia of the People's Republic of China (95 editions).
上述酊剂的制备方法是:用10000毫升浓度为75%的酒精浸泡上述组分药剂,常温常下浸泡7-10天,过滤装瓶即可使用。The preparation method of the above-mentioned tincture is as follows: 10,000 milliliters of alcohol with a concentration of 75% is used to soak the above-mentioned component medicaments, soak for 7-10 days at normal temperature and under normal temperature, filter and bottle for use.
本发明抗皮肤癣菌的实验Anti-dermatophyte experiment of the present invention
培养基:沙氏培养基(Sabouraud氏葡萄糖琼脂)菌种:白色念珠菌(C andidaalbicans)红色毛癣菌(Trichophyton rubrum)石膏样毛癣菌(T.interdigitale)絮状表皮癣菌(Epidermophylon floccosu)Medium: Sabouraud's Dextrose Agar) Strains: Candida albicans, Trichophyton rubrum, T.interdigitale, Epidermophylon floccosu
方法:method:
1、制备沙氏培养基、装三角瓶、用高压灭菌。1. Prepare Sabouraud medium, fill it into a Erlenmeyer flask, and sterilize it with high pressure.
2、用无菌方法取皮癣菌注入消毒的平皿内(平皿直径为10cm),然后倾入沙氏基(每皿20ml)。2. Get the dermatophyte and inject it into a sterilized petri dish (the diameter of the petri dish is 10cm) with an aseptic method, then pour into Sabouraud's base (every dish 20ml).
3、每皿接种上述四种霉菌(直径为0.5毫米的菌团)。3. Each dish was inoculated with the above four kinds of molds (a 0.5 mm diameter cluster).
4、保湿培养37℃,一周后观察结果。4. Moisturize and cultivate at 37°C, and observe the results after one week.
5、观察方法:量菌落直径(mm)与对照比较,观察菌落生长状态及有无杂菌生长。5. Observation method: measure the colony diameter (mm) and compare it with the control, observe the growth state of the colony and whether there is growth of miscellaneous bacteria.
由表1可以看出,本发明象克霉唑癣药水一样对皮肤癣菌(红色毛癣菌、石膏样毛癣菌和絮状表皮癣菌)以及深部真菌白色念珠菌均有明显的抗菌作用,使菌落缩小(n=5,P<0.001)。从表1中还取看出,本发明的抗真菌作用大于克霉唑癣药水,主要表现在两个方面:其一:克霉唑癣药水在稀释60倍时,其抗菌作用即消失,菌落直径接近对照组(n=5,P>0.05)而本发明在稀释120倍时仍然有明显地抗菌作用(n=5,P<0.001)。其二:克霉唑癣药水及其10倍稀释液只能使菌落缩小,而本发明及其60倍稀释液则使培养基中皮肤癣菌(红、石、絮)的菌落消失,120倍稀释液仍能使絮状表皮癣菌的菌落消失。提示克霉唑癣药水只能抑制真菌的生长,而本发明可能还有杀菌作用。从表中还可以看出,本发明在60倍稀释液时对白色念珠菌的作用已基本消失(n=5,P>0.05),而120倍稀释液对皮肤癣菌(红、石、絮)仍然有明显地抗菌作用(n=5,P<0.001)。提示本发明对表皮真菌的抗菌作用大于对深部真菌的作用。As can be seen from Table 1, the present invention has obvious antibacterial action to dermatophytes (Trichomyces rubrum, Trichophyton gypsum and Epidermophyton flocculus) and deep fungus Candida albicans the same as clotrimazole ringworm medicine , making the colony shrink (n=5, P<0.001). Also get from table 1 and find out, antifungal effect of the present invention is greater than clotrimazole tinea potion, mainly shows in two aspects: one: when clotrimazole tinea potion is diluted 60 times, its antibacterial effect promptly disappears, and bacterial colony The diameter is close to that of the control group (n=5, P>0.05), while the present invention still has obvious antibacterial effect when diluted 120 times (n=5, P<0.001). Its two: clotrimazole ringworm liquid medicine and 10 times of dilution thereof can only make bacterium colony dwindle, and the present invention and 60 times of dilution thereof then make the bacterium colony of dermatophyte (red, stone, floc) disappear in the culture medium, 120 times The diluent still caused the colonies of Epidermophyton flocculus to disappear. It is suggested that the clotrimazole tinea potion can only inhibit the growth of fungi, but the present invention may also have a bactericidal effect. Can also find out from the table, the present invention has substantially disappeared (n=5, P>0.05) to the effect of Candida albicans when 60 times of dilutions, and 120 times of dilutions are to dermatophyte (red, stone, floc) ) still had obvious antibacterial effect (n=5, P<0.001). It is suggested that the antibacterial effect of the present invention on epidermal fungi is greater than that on deep fungi.
表2:本发明治疗皮肤癣症例疗效分析
临床疗效观察:Observation of clinical efficacy:
自1992年5月至1998年2月,在湖北三峡学院医学院皮肤科、宜昌市中心医院皮肤科,宜昌干休所医院门诊部共治疗各种皮肤癣症352例,其中男182例,女170例。From May 1992 to February 1998, in the Dermatology Department of Hubei Three Gorges University School of Medicine, the Dermatology Department of Yichang Central Hospital, and the outpatient department of Yichang Cadre Rest Hospital Hospital, a total of 352 cases of skin ringworm were treated, including 182 cases of males and 182 cases of females. 170 cases.
使用方法:清洁皮肤,待皮肤干燥后在病表面涂擦本药,每日2-3次。Usage: Clean the skin, apply this medicine on the affected surface after the skin is dry, 2-3 times a day.
疗效判断标准:①临床治愈:皮肤癣症的瘙痒、脱屑脱皮、皲裂消失,皮肤颜色恢复正常;②显效:皮肤癣症的皲裂、脱屑脱皮消失,仍有皮肤瘙痒;③好转:皮肤癣症的皲裂消失,脱屑脱皮减轻,仍有瘙痒;④无效:用药后无明显好转;⑤复发:连续用药三个月后停药复发者。Judgment criteria for curative effect: ①Clinical cure: the itching, desquamation and peeling of skin ringworm disappeared, and the skin color returned to normal; The chapped symptoms disappear, desquamation and desquamation are relieved, and pruritus is still present; ④ invalid: no obvious improvement after medication;
黄连为毛莨科多年生草本植物黄连(Copitischinesis Franch)的根茎,根须及叶。祖国医学认为黄连性味苦寒,具有清热燥湿、泻火解毒之功效。主治痈疖火毒、湿疮作痒、目赤肿痛等症,内服、外用均有良效。现代医学认为黄连具有广谱抗菌作用,对溶血性链球菌、脑膜炎球菌、肺炎双球菌、金黄色葡萄球菌以及痢疾杆菌、白喉杆菌、枯草杆菌、破伤风杆菌、结核杆菌等多种G+、G-细菌均有较强抑菌作用,对十余种常见致病性真菌也有广泛而显著的抑制作用。黄连中的有效成分小薜碱尚有解热、镇痛和局部麻醉作用。Coptis chinensis is the rhizome, roots and leaves of Copitis chinesis Franch, a perennial herb of Ranunculaceae. Chinese medicine believes that Coptidis is bitter and cold in nature, and has the effects of clearing away heat and dampness, purging fire and detoxifying. It is mainly used to treat carbuncle, furuncle, fire poison, eczema, itching, red eyes, swelling and pain, etc. It can be taken orally or externally. Modern medicine believes that Coptidis Rhizome has a broad-spectrum antibacterial effect, and it is effective against various G+, G - Bacteria have a strong antibacterial effect, and it also has a wide and significant inhibitory effect on more than ten common pathogenic fungi. The active ingredient in Coptis chinensis is also antipyretic, analgesic and local anesthetic.
本发明的抗菌作用及治疗皮肤感染性疾病疗效分析:Analysis of the antibacterial effect of the present invention and treatment of skin infectious diseases:
实验研究Experimental Study
材料:培养基 肉汤琼脂Material: Media Broth Agar
菌种 金黄色葡萄球菌、伤寒杆菌、大肠杆菌、绿脓杆菌均系湖北三峡学院医学院微生物教研室保存菌种。Strains Staphylococcus aureus, Bacillus typhi, Escherichia coli, and Pseudomonas aeruginosa are all strains preserved in the Department of Microbiology, School of Medicine, Hubei Three Gorges University.
药物 皮康酊由黄连等十几味中药组成,所用中药均系宜昌市中心医院中药房提供;硫酸庆大霉素注射液由湖北宜昌制药厂生产。Drug Pikang Tincture is composed of more than a dozen traditional Chinese medicines such as Coptis chinensis, all of which are provided by the Chinese Pharmacy of Yichang Central Hospital; Gentamicin Sulfate Injection is produced by Hubei Yichang Pharmaceutical Factory.
动物 家兔由武汉同济医科大学实验动物中心提供。Animals Rabbits were provided by the Experimental Animal Center of Tongji Medical University, Wuhan.
方法与结果:Method and Results:
抗细菌试验 取培养6小时肉汤菌液(细菌数均为9亿/mL),无菌盐水稀释成1/500。取50个直径9cm无菌平皿,分别加入四种稀释菌液1mL,然后倒入溶化冷至45℃琼脂培养基30mL,立即旋转混匀。凝固后,用外径6mm灭菌玻管于平板上打5个孔,并取出孔中琼脂。5个孔中分别加入75%酒精、硫酸庆大霉素(gentamicin)注射液、100%本发明药剂(原液)、1.67%本发明药剂(1∶60稀释液)和0.83%本发明药剂(1∶120稀释液)各100uL。37℃温箱中培养24小时,测出抑菌圈。Anti-bacterial test Take the cultured broth for 6 hours (the number of bacteria is 900 million/mL), and dilute it to 1/500 with sterile saline. Take 50 sterile plates with a diameter of 9 cm, add 1 mL of the four diluted bacterial solutions, and then pour 30 mL of agar medium that has been cooled to 45 °C, and immediately rotate and mix. After solidification, use a sterilized glass tube with an outer diameter of 6mm to punch 5 holes on the plate, and take out the agar in the holes. Add 75% alcohol, gentamicin sulfate (gentamicin) injection, 100% medicament of the present invention (stock solution), 1.67% medicament of the present invention (1:60 dilution) and 0.83% medicament of the present invention (1:60 dilution) in 5 holes respectively. : 120 dilution) each 100uL. Cultivate in a 37°C incubator for 24 hours, and measure the inhibition zone.
由表3可见100%、1.67%和0.83%的本发明药剂对金葡菌、伤寒杆菌、大肠杆菌、绿脓杆菌均有明显的抑菌作用,且此作用均大于75%酒精,提示本发明中的中药成分与75%酒精有抗菌协同作用。从表中还可以看出其原液对绿脓杆菌和金葡菌的抗菌作用均大于硫酸庆大霉素注射液,这可能是本发明对烧伤、烫伤后创面感染疗效好的理论依据。As seen from Table 3, 100%, 1.67% and 0.83% of the medicament of the present invention have obvious bacteriostasis to Staphylococcus aureus, Salmonella typhi, Escherichia coli, Pseudomonas aeruginosa, and this effect is all greater than 75% alcohol, suggesting the present invention The traditional Chinese medicine ingredients and 75% alcohol have antibacterial synergistic effect. It can also be seen from the table that the antibacterial effect of its stoste on Pseudomonas aeruginosa and Staphylococcus aureus is greater than that of gentamicin sulfate injection, which may be the theoretical basis for the good curative effect of the present invention on burns and wound infection after scalding.
皮肤刺激性试验 家兔25只,体重1.5-2kg,雌雄兼用。随机分为五组;I组以75%酒精涂擦家兔两耳;II组以硫酸庆大霉素注射液涂擦家兔两耳。III组以本发明原液涂擦家兔两耳;IV组以1.67%本发明涂擦家兔两耳;V组以0.83%本发明涂擦家兔两耳。观察并记录两耳皮肤有无红斑、水肿等皮肤刺激现象。Skin irritation test 25 rabbits, weighing 1.5-2kg, both male and female. They were randomly divided into five groups; group I rubbed both ears of rabbits with 75% alcohol; group II rubbed both ears of rabbits with gentamicin sulfate injection. Group III rubbed both ears of rabbits with the stock solution of the present invention; group IV rubbed both ears of rabbits with 1.67% of the present invention; group V rubbed both ears of rabbits with 0.83% of the present invention. Observe and record whether there are skin irritations such as erythema and edema on the skin of both ears.
试验结果发现,除硫酸庆大霉素注射液无任何皮肤刺激症状外,本发明原液、1.67%和0.83%浓度均与75%酒精一样可致兔耳出现短暂的红斑,但无水肿、无水泡,一小时后消失,这可能是酒精扩血管作用所致。提示皮康酊无明显的皮肤刺激性。The test results found that, except that the gentamicin sulfate injection did not have any skin irritation symptoms, the stock solution of the present invention, 1.67% and 0.83% concentrations could cause transient erythema in rabbit ears as well as 75% alcohol, but without edema and blisters , disappeared after an hour, which may be caused by the vasodilator effect of alcohol. It is suggested that Pikang tincture has no obvious skin irritation.
2、临床疗效观察2. Observation of clinical efficacy
1992年5月至1998年2月五年期间,在湖北三峡学院医学院附属医院、宜昌市中心医院、宜昌干休所医院门诊部共治疗各种皮肤感染性疾病2648例,其中男865例,女1783例。使用方法:清洁皮肤,待皮肤干燥后在病灶表面涂擦本药,每日2-3次。注意事项:禁止将本药制成药物纱条敷于创面或填塞于创口深处。疗效判定标准:①临床治愈:皮肤炎症消退,创面愈合;②显效:皮肤炎症明显减轻,创面缩小80%以上;③好转:皮肤炎症有所减轻,创面缩小60%以上;④无效:用药后皮肤炎症无明显改善;⑤复发:青春痘患者连续用药1个月内复发者。During the five-year period from May 1992 to February 1998, a total of 2,648 cases of various skin infections were treated in the outpatient departments of the Affiliated Hospital of Hubei Three Gorges University School of Medicine, Yichang Central Hospital, and Yichang Cadre Rest Hospital, including 865 male cases. 1783 cases were female. Method of use: clean the skin, apply this medicine on the lesion surface after the skin is dry, 2-3 times a day. Precautions: It is forbidden to make this drug into a drug gauze and apply it to the wound or stuff it deep into the wound. Judgment criteria for curative effect: ①Clinical cure: skin inflammation subsides, and wound surface heals; ②Marked effect: skin inflammation is significantly reduced, and wound surface shrinks by more than 80%; ③Improved: skin inflammation is alleviated, and wound surface shrinks by more than 60%; No significant improvement in inflammation; ⑤Recurrence: Acne patients relapsed within 1 month of continuous medication.
由表4可以看出,2648例患者,治愈216人,显效312人,总有效率为99.8%。青春痘患者连续用药一月内复发87人,复发率为71%,总复发率只有3.3%,连续使用仍然有效。As can be seen from Table 4, among the 2648 patients, 216 were cured, 312 were markedly effective, and the total effective rate was 99.8%. 87 acne patients relapsed within one month of continuous medication, the recurrence rate was 71%, and the total recurrence rate was only 3.3%. Continuous use is still effective.
对一般皮肤炎症,用药后24小时内即可显效,三天后多可治愈。对经久不愈的皮肤溃烂,用药后显现出良好的收敛作用,使创面干燥,溃疡面缩小,一般连续用药两周后可痊愈。对烧伤、烫伤后的创面感染(包括绿脓杆菌感染)也有很好的治疗效果,多数患者在连续用药1-2周后创面收口痊愈。For general skin inflammation, it can be effective within 24 hours after taking the medicine, and it can be cured after three days. For skin ulcers that have not healed for a long time, it shows a good astringent effect after medication, which makes the wound surface dry and the ulcer surface shrinks. Generally, it can be cured after two weeks of continuous medication. It also has a good therapeutic effect on wound infection (including Pseudomonas aeruginosa infection) after burns and scalds, and most patients heal after continuous medication for 1-2 weeks.
综上所述,本发明以中药黄连为主药,配伍组方而成的中药制剂,其中不含抗生素,毒性低、副作用小,疗效高。在5年多的试用过程中,我们发现该药具有以下优点:①疗效高:对手、足癣和皮肤癣症,用药10分钟后即可产生止痒效果,连续用药一周后显效,一月后大部分皮损症状消失,多数患者连续用药三个月后症愈,且复发率低(26.1%),若在第二年春初(1-2月份)再连续用药1-2个月,可杜绝复发,对一般皮肤炎症,用药后24小时内即可显效,三天后多可治愈。对经久不愈的皮肤溃烂,用药后显现出良好的收敛作用,使创面干燥,溃疡面缩小,一般连续用药两周后可痊愈。对烧伤、烫伤后的创面感染(包括绿脓杆菌感染)也有很好的治疗效果,多数患者在连续用药1-2周后创面收口痊愈。②对皮肤刺激性小,因该药为酊剂,含有酒精,除对创面有短暂的疼痛刺激外,不会引起皮肤红肿、大片落皮现象;③本品不含皮质激素类物质,不会引起色素沉着(本药为中药制剂,涂擦后会在皮肤上留下中药本身的浅黄色,用肥皂水清洗即掉);④本品不含抗生素,本品长期使用不会产生耐药性和过敏反应;⑤该药皮肤穿透力强,使用方便,只需在创伤表面轻轻涂擦,药物便可渗入组织发挥作用;⑥本品的有效期长达5年以上。In summary, the present invention is a traditional Chinese medicine preparation made of Chinese medicine Coptidis Rhizoma as the main medicine and formulated in a compatible formula, which does not contain antibiotics, has low toxicity, small side effects and high curative effect. During the trial process of more than 5 years, we found that the drug has the following advantages: ① High curative effect: For hands, tinea pedis and skin ringworm, it can produce antipruritic effect after 10 minutes of medication, and it will be effective after one week of continuous medication, and after one month Most of the symptoms of skin lesions disappeared, and most patients recovered after three months of continuous medication, and the recurrence rate was low (26.1%). Recurrence, for general skin inflammation, can be markedly effective within 24 hours after medication, and can be cured after three days. For skin ulcers that have not healed for a long time, it shows a good astringent effect after medication, which makes the wound surface dry and the ulcer surface shrinks. Generally, it can be cured after two weeks of continuous medication. It also has a good therapeutic effect on wound infection (including Pseudomonas aeruginosa infection) after burns and scalds, and most patients heal after continuous medication for 1-2 weeks. ②Slightly irritating to the skin, because the medicine is a tincture containing alcohol, it will not cause redness and swelling of the skin, and large flakes of skin except for short-term pain stimulation on the wound; ③This product does not contain corticosteroids and will not cause Pigmentation (this medicine is a traditional Chinese medicine preparation, it will leave the light yellow color of the traditional Chinese medicine itself on the skin after rubbing, and it will disappear after washing with soapy water); ④ This product does not contain antibiotics, and long-term use of this product will not produce drug resistance and Allergic reaction; ⑤ The drug has strong skin penetration and is easy to use, just rub it gently on the wound surface, and the drug can penetrate into the tissue to play a role; ⑥ The validity period of this product is more than 5 years.
表1:本发明(皮癣净)对皮肤真菌的抗菌作用Table 1: the antibacterial effect of the present invention (dermatosis net) on skin fungus
( x±S)( x±S)
菌 落(mm)分 组 药 物 浓 度 nColony (mm) Grouping Drug Concentration n
白色念珠 红色毛癣 石膏样毛癣 絮状表皮癣1 空 白 - 12 8.3±3 36±9 22.9±9 21.0±62 克霉唑 原液 5 0.5±0.2*** 0.6±0.3*** 0.8±0.2*** 0.5±0.2***3 克霉唑 1∶10稀释 5 1.8±0.4*** 0.8±0.4*** 0.6±0.3*** 1.0±0.1***4 克霉唑 1∶60稀释 5 6.5±2 42.0±3 24.0±4 23.2±25 皮癣净 原液 5 0.8±0.3*** 0*** 0*** 0***6 皮癣净 1∶60稀释 5 5.8±0.8 0*** 0*** 0***7 皮癣净 1∶120 5 5.8±0.8 0.18±0.08*** 0.18±0.08*** 0***8 皮癣净 1∶240 5 6.8±1 41.0±2 24.8±3 21.2±2Rosary albicans Trichomonad rubrum Trichophyton gypsum Epidermophyma flocculus1 Blank - 12 8.3±3 36±9 22.9±9 21.0±62 Clotrimazole stock solution 5 0.5±0.2 *** 0.6±0.3 *** 0.8±0.2 * ** 0.5±0.2 *** 3 Clotrimazole 1∶10 dilution 5 1.8±0.4 *** 0.8±0.4 *** 0.6±0.3 *** 1.0±0.1 *** 4 Clotrimazole 1∶60 dilution 5 6.5±2 42.0±3 24.0 ±4 23.2±25 Pishaojing stock solution 5 0.8±0.3 *** 0 *** 0 *** 0 *** 6 Pishaojing 1∶60 dilution 5 5.8±0.8 0 ** * 0 *** 0 *** 7 Dishinajing 1∶120 5 5.8±0.8 0.18±0.08 *** 0.18±0.08 *** 0 *** 8 Dishinajing 1∶240 5 6.8±1 41.0±2 24.8±3 21.2±2
与空白对照比:***P<0.001Compared with blank control: ***P<0.001
表3:本发明的抗菌作用Table 3: Antibacterial effect of the present invention
抑菌圈(mm) x±SD药 物 浓 度 nZone of Inhibition (mm) x±SD drug concentration n
(%) 金葡萄 伤寒杆菌 大肠杆菌 绿脓杆菌酒精 75 10 7.6±2 7.3±0.8 5.9±0.6 2.0±0.1庆大霉素 6.78 10 15.2±2*** 10.5±0.9** 23.0±2*** 12.7±2***本发明 100 10 23.0±2*** 18.5±0.9*** 22.7±1.5*** 18.2±0.6***本发明 1.67 10 15.6±0.7*** 12.6±0.9** 12.0±1*** 12.5±0.7***本发明 0.83 10 12.6±1*** 10.3±0.8 9.7±0.9*** 8.2±0.6*** (%) Staphylococcus aureus Typhi Escherichia coli Pseudomonas aeruginosa Alcohol 75 10 7.6±2 7.3±0.8 5.9±0.6 2.0±0.1 Gentamicin 6.78 10 15.2±2 *** 10.5±0.9 ** 23.0±2 *** 12.7±2 *** Invention 100 10 23.0±2 *** 18.5±0.9 *** 22.7±1.5 *** 18.2±0.6 *** Invention 1.67 10 15.6±0.7 *** 12.6±0.9 ** 12.0 ±1 *** 12.5±0.7 *** Invention 0.83 10 12.6±1 *** 10.3±0.8 9.7±0.9 *** 8.2±0.6 ***
表4:本发明治疗皮肤感染性疾病的疗效分析疾 病 例 数 治 愈 显 效 好 转 无 效 有效率 复 发 复发率Table 4: Analysis of the curative effect of the present invention on treating skin infectious diseases
(人) (人) (人) (人) (人) (人) (%) (%)青 春 痘 1230 986 174 70 0 100 87 7.1疖 疮 痛 910 758 83 69 0 100 0 0手术及创伤感染 230 220 8 2 0 100 0 0烧伤烫伤感染 192 148 27 17 0 100 0 0经久不愈皮肤溃疡 86 56 20 6 4 95 0 0合 计 2648 2168 312 164 4 99.8 87 3.3(Person) (person) (person) (person) (person) (person) (person) (person) (percent) ( %) ( %) youth acne 1230 986 174 70 0 100 87 7.1 sore 910 758 83 69 0 100 0 0 surgery and trauma infection and trauma infection 230 220 8 2 0 100 0 0 burns Burning infection 192 148 27 17 0 100 0 0 Do not heal skin ulcer 86 56 20 6 4 95 0 0 combination 2648 312 164 49.8 87 3.3
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99116454A CN1095377C (en) | 1999-04-29 | 1999-04-29 | Medicine for treating skin ringworm and dermatitis and preparation process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99116454A CN1095377C (en) | 1999-04-29 | 1999-04-29 | Medicine for treating skin ringworm and dermatitis and preparation process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1240146A CN1240146A (en) | 2000-01-05 |
| CN1095377C true CN1095377C (en) | 2002-12-04 |
Family
ID=5279270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99116454A Expired - Fee Related CN1095377C (en) | 1999-04-29 | 1999-04-29 | Medicine for treating skin ringworm and dermatitis and preparation process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1095377C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0113348D0 (en) | 2001-06-01 | 2001-07-25 | Mars Uk Ltd | Skin diet |
| KR100975426B1 (en) * | 2007-11-29 | 2010-08-12 | 김진홍 | Composition for the prevention and treatment of allergic skin disease using herbal extract |
| CN102205022B (en) * | 2011-05-25 | 2012-08-22 | 吴培春 | Chinese medicinal preparation for treating mycotic infection and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1048657A (en) * | 1989-07-10 | 1991-01-23 | 郭毅 | The compound method of treatment psoriasis and tinea cruris medicament |
| CN1063412A (en) * | 1991-01-14 | 1992-08-12 | 樊芝芹 | The manufacture method of Yiwohu tinea-curing medicine |
| CN1078645A (en) * | 1993-04-20 | 1993-11-24 | 谢民福 | Antiphlogistic oil for external use and compound method thereof |
| CN1080865A (en) * | 1993-01-05 | 1994-01-19 | 梁建奇 | Dermopathic Chinese medicine of a kind of treatment and preparation method |
| CN1088811A (en) * | 1992-12-29 | 1994-07-06 | 李太江 | Medicinal liquid for treating tinea |
| CN1098301A (en) * | 1993-08-04 | 1995-02-08 | 赵世平 | Skin-care tinea pedis medicine and preparation method thereof |
| CN1142387A (en) * | 1996-06-11 | 1997-02-12 | 谢志庆 | Chinese medicine paste |
-
1999
- 1999-04-29 CN CN99116454A patent/CN1095377C/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1048657A (en) * | 1989-07-10 | 1991-01-23 | 郭毅 | The compound method of treatment psoriasis and tinea cruris medicament |
| CN1063412A (en) * | 1991-01-14 | 1992-08-12 | 樊芝芹 | The manufacture method of Yiwohu tinea-curing medicine |
| CN1088811A (en) * | 1992-12-29 | 1994-07-06 | 李太江 | Medicinal liquid for treating tinea |
| CN1080865A (en) * | 1993-01-05 | 1994-01-19 | 梁建奇 | Dermopathic Chinese medicine of a kind of treatment and preparation method |
| CN1078645A (en) * | 1993-04-20 | 1993-11-24 | 谢民福 | Antiphlogistic oil for external use and compound method thereof |
| CN1098301A (en) * | 1993-08-04 | 1995-02-08 | 赵世平 | Skin-care tinea pedis medicine and preparation method thereof |
| CN1142387A (en) * | 1996-06-11 | 1997-02-12 | 谢志庆 | Chinese medicine paste |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1240146A (en) | 2000-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8765819B2 (en) | Composition comprising benzoic acid in combination with organic acid preservatives as active ingredients and the use thereof | |
| CN111803624A (en) | Skin antibacterial gel preparation containing transfer factor and preparation method thereof | |
| CN1251738C (en) | Chinese medicine for treating ashen nail and its preparation method | |
| CN1095377C (en) | Medicine for treating skin ringworm and dermatitis and preparation process | |
| CN1557286A (en) | Compound chlorhexidine acetate spray | |
| CN117018053A (en) | Antibacterial spray for feet and preparation method and application thereof | |
| CN106511478A (en) | Compound essential oil for treating dog tinea as well as preparation method and applications of compound essential oil | |
| CN101332286B (en) | Traditional Chinese medicine composition for treating skin disease and preparation method thereof | |
| CN1583165A (en) | Gel gent of Chiense forest frog bactericidal peptide | |
| CN1985883B (en) | A kind of antifungal pharmaceutical composition and its preparation method and application | |
| WO2019123483A1 (en) | A herbal antiseptic and wound healing preparation | |
| CN109464328A (en) | Plant type bacterio static itching-relieving liquid | |
| CN1191066C (en) | Externally-used disinfector | |
| CN105079305A (en) | Antisepsis and anti-inflammation external traditional Chinese medicine compound gel and preparation method thereof | |
| CN102961457B (en) | Veterinary drug used for treating eczema of pet | |
| LU506950B1 (en) | A gel agent for treating pet skin diseases and its preparation method | |
| CN1454656A (en) | Medicine for curing leuconychia and hand-foot ringworm and preparing method thereof | |
| CN105582529A (en) | Pharmaceutical composition for treating beriberi | |
| CN1197595C (en) | Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing | |
| CN111388529A (en) | A kind of medicinal composition for treating onychomycosis and preparation method thereof | |
| CN1257116A (en) | Medicated soap with functions of tonifying skin and disinfection | |
| CN114272240B (en) | Anti-infection compound preparation and application thereof | |
| CN118286325B (en) | Traditional Chinese medicine ointment for treating microbial infection skin diseases and preparation method and application thereof | |
| CN117018052A (en) | Liquid medicine for treating onychomycosis and preparation method and application thereof | |
| CN1275616C (en) | A pharmaceutical composition for treating burn and scald |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SANXIA UNIVERSITY Free format text: FORMER OWNER: SHANXIA COLLEGE, HUBEI Effective date: 20030103 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20030103 Patentee after: China Three Gorges University Patentee before: Shanxia College |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |